Interventional Radiology Market Set for Steady Growth to USD 49.43 Billion by 2035, Led by North America's 39% Market Share | DataM Intelligence

Leander, Texas - The Global Interventional Radiology Market is valued at approximately USD 30.34 billion in 2025 and is projected to reach around USD 49.43 billion by 2035, growing at a CAGR of about 5.2% during the forecast period from 2025 to 2035.

This growth is driven by increasing adoption of minimally invasive, image-guided procedures, advancements in imaging technologies, and rising demand for treatments for chronic illnesses such as cardiovascular disorders and cancer.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/interventional-radiology-market?ram

United States: Key Industry Developments
✅ October 2025: Esaote Group unveiled AI-powered medical imaging solutions including the e-SPADES AI platform for MRI, Augmented Insight AI for ultrasound, and the MyLab C30 ultrasound system, enhancing procedural accuracy in interventional radiology.

✅ October 2025: The interventional radiology product market is growing rapidly with continuous technological innovations such as AI-driven imaging analysis tools that improve diagnostic accuracy and real-time procedural guidance; major players like Medtronic and Boston Scientific are focused on smart catheters and bioresorbable stents.

✅ September 2025: Expansion in ambulatory surgical centers for interventional radiology systems was noted, with portable and compact devices designed for outpatient procedures gaining popularity, reflecting a shift towards same-day discharge and outpatient care protocols.

Japan: Key Industry Developments
✅ October 2025: Advancements in AI and robotics are increasingly integrated into interventional radiology systems, improving treatment precision and patient outcomes; Japanese manufacturers are focusing on combining imaging modalities like MRI, CT, and ultrasound with minimally invasive devices.

✅ August 2025: Strategic partnerships and government support have increased for innovation in interventional radiology products, emphasizing development of hybrid operating rooms equipped with advanced imaging systems suitable for complex procedures.

✅ July 2025: Leading Japanese healthcare companies adopted cloud-native PACS systems for remote interventional radiology diagnostics, improving workflow efficiency and enabling better patient management through enhanced connectivity.

Key Merges and Acquisitions (2025):
-Stryker completed a USD 4.9 billion acquisition of Inari Medical, granting immediate entry into the high-growth venous thrombectomy segment and expanding its vascular franchise.

-Boston Scientific broadened its liver-oncology portfolio by acquiring Intera Oncology devices that provide hepatic arterial infusion chemotherapy.

-Argon Medical expanded its oncology intervention portfolio by acquiring SeQure and DraKon microcatheters, enhancing precision therapeutic delivery in cancer treatments.

-Teleflex completed its acquisition of Biotronik's vascular intervention business, reinforcing its position in vascular intervention devices.

-GE HealthCare signed an agreement to acquire icometrix, a developer of AI-powered brain MRI analysis tools, strengthening its neurology portfolio in Alzheimer's disease and multiple sclerosis.

-Aptyx expanded its interventional portfolio by acquiring Medical Murray's North Carolina facility, specializing in catheter-based interventional products and transcatheter implants.

Tyber Medical, Intech, and Resolve Surgical Technologies merged to create a unified medtech solutions provider with enhanced product development and after-sales service capabilities.

-Aspen Medical Products acquired Advanced Orthopaedics to extend its braces and supports portfolio, tapping into orthopedic soft goods and broadening its reach in interventional care.

-Integer acquired Precision Coating to improve its advanced coating technology capabilities, critical for implantable interventional devices.

Market Segmentation Analysis:
-By Product Type: Imaging Systems and Ultrasound Lead Market Share
Imaging systems hold around 46.34% market share in 2024, including MRI, CT scanners, and angiography systems, as they are crucial for procedure planning and guidance. Ultrasound imaging systems lead growth and market presence in 2024 due to rising adoption by healthcare facilities.​

-By Application: Cardiology Dominates
The cardiology segment commands the largest share with approximately 33.7% of the application market in 2025, driven by the high prevalence of cardiovascular diseases and preference for minimally invasive cardiac procedures like angioplasty and embolization. Oncology is the fastest-growing application segment.​

-By End-Users: Hospitals Dominate
Hospitals represent the leading end-user segment due to their extensive adoption of interventional radiology technology for diverse procedures, followed by ambulatory surgical centers and diagnostic centers. Hospitals capture the major market share given the infrastructure and procedure volume available.

Purchase this report before year-end and unlock an exclusive 30% discount: https://www.datamintelligence.com/buy-now-page?report=interventional-radiology-market?ram (Purchase 2 or more Reports and get 50% Discount)

Growth Drivers:
-Rising prevalence of chronic diseases such as cancer, cardiovascular, and gastrointestinal disorders increasing demand for minimally invasive procedures.

-Technological advancements in imaging modalities including AI, virtual reality, multimodal imaging, and real-time image-guided procedures improving precision and outcomes.

-Growing awareness about the benefits of interventional radiology like reduced hospital stays, cost-effectiveness, and less invasive treatment.

-Expanding applications of interventional radiology in oncology, pain management, and other new treatment areas.

-Increasing healthcare infrastructure and favorable reimbursement policies facilitating broader adoption.

-Rising investments by key market players and startups in developing advanced IR technologies.

Regional Insights:
-North America: North America dominates the global interventional radiology market, expected to hold about 39.0% in 2025. This is attributed to a focus on minimally invasive procedures, high healthcare spending, and advanced infrastructure. The U.S. is a major contributor to this market.

-Europe: Europe holds a significant market share, around 28% in 2024. Key growth drivers include an aging population, strong healthcare systems, and increasing demand for minimally invasive procedures.

-Asia-Pacific: This is the fastest-growing region, accounting for approximately 36% of the global market in 2023. Factors like urbanization, rising incomes, and increasing prevalence of chronic diseases contribute to this growth. Expanding healthcare infrastructure and government initiatives are also important.

-Latin America: This region holds a smaller but growing share, around 5% of the global market. Improved diagnostic capabilities and a focus on chronic disease management are key drivers.

-Middle East & Africa: This region represents a smaller but expanding market segment, contributing close to 7% of the market share. Increased healthcare investments and a focus on medical tourism are driving growth.

Speak to Our Analyst and Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/interventional-radiology-market?ram

Key Players:
GE Healthcare | Siemens Healthineers | Canon Medical | Philips | Fujifilm | Shimadzu Corporation

Key Highlights (Top 5 Key Players) for Interventional Radiology Market:
-Siemens Healthineers reported significant growth with advanced therapies revenue increasing by 8.0% in 2025, supported by strategic investments including a USD 150 million facility expansion in the U.S. Siemens, as a Tier 1 leader, holds a substantial share in the market, contributing to the global interventional radiology market projected at USD 30.3 billion in 2025.

-GE Healthcare generated robust revenue within the interventional radiology segment as a principal Tier 1 company, playing a dominant role in the imaging systems market contributing to sector revenues reflecting the global market size.

-Philips Healthcare stands among the top Tier 1 players, with focused investments in AI and helium-free MRI technology enhancing market position in the interventional radiology field.

-Fujifilm Holdings Corporation, also a Tier 1 participant, holds notable market presence with innovative medical imaging solutions contributing a significant share to the overall interventional radiology revenue.

-Canon Medical Systems, classified under Tier 2 companies, efficiently caters to specialized clinical demands and emerging medical needs, thereby securing a meaningful portion of the interventional radiology market revenue.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?ram

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.